A first patient in Canada has been dosed in a Phase 1 clinical trial of DA01, a cell-based investigational therapy…
Articles by Margarida Maia, PhD
A team of scientists at the University of Cincinnati, in Ohio, has received a grant worth $1.2 million from the…
Iktos is working with Astrogen to use artificial intelligence (AI) to identify small molecules as candidates for the…
Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of…
Argobio and GeneCode are teaming up to develop small molecules mimicking glial cell-derived neurotrophic factor (GDNF), a protein…
A computer software that tracks how facial muscles move during a video selfie may be able to help predict whether…
A gene therapy targeting the substantia nigra, the brain region with dopamine-producing nerve cells, may boost the benefits of…
Mapping of a brain circuit that is of particular relevance to neurological diseases such as Parkinson’s and Huntington’s…
Mission Therapeutics has been awarded a Therapeutic Pipeline Program grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to advance…
A deep brain stimulation (DBS) protocol that targets specific sets of nerve cells, or neurons, in the brain produced long-lasting effects…